Methods and compositions for inhibition of angiogenesis
US5593990A · kind A · utility
153Cited by
11References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 13, 1995 |
| Grant date | Jan 14, 1997 |
| Priority date | — |
| Expiry date | Jan 13, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis and to treat disease states resulting from angiogenesis. Importantly, these compounds can be administered orally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.